Phenylpiracetam
Synthetic racetam compound studied for cognitive and fatigue effects in cerebrovascular insufficiency, with limited human evidence.
Phenylpiracetam
Synthetic racetam compound studied for cognitive and fatigue effects in cerebrovascular insufficiency, with limited human evidence.
Weak evidence from small Russian trials; skip in favor of better-studied cognitive supplements.
Phenylpiracetam is a synthetic racetam derivative developed in Russia as a prescription drug (Phenotropil); it is not approved as a dietary supplement in the US. The added phenyl group increases lipophilicity and confers psychostimulant properties, likely via modulation of acetylcholine, glutamate, and dopamine signaling. Small Russian clinical trials suggest modest improvements in cognitive function, fatigue, and functional recovery after stroke in specific patient groups. Healthy adults have almost no published data, making recreational use experimental. It may be considered by individuals w
Proven Benefits
Protocol
Onset Time
Who Should Consider
How It Works
The phenyl group increases lipophilicity and confers psychostimulant properties, likely via dopamine reuptake inhibition and modulation of nicotinic acetylcholine and NMDA receptors. This is thought to increase neuronal excitability and neurotransmitter release, though direct human mechanistic data remain sparse.